| __timestamp | Agios Pharmaceuticals, Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 9335772 |
| Thursday, January 1, 2015 | 141827000 | 999000 |
| Friday, January 1, 2016 | 220163000 | 978000 |
| Sunday, January 1, 2017 | 292681000 | 952000 |
| Monday, January 1, 2018 | 1397000 | 956000 |
| Tuesday, January 1, 2019 | 1317000 | 8122999 |
| Wednesday, January 1, 2020 | 2805000 | 8712000 |
| Friday, January 1, 2021 | 18777000 | 13980000 |
| Saturday, January 1, 2022 | 1704000 | 21135000 |
| Sunday, January 1, 2023 | 9504000 | 10755000 |
| Monday, January 1, 2024 | 4165000 |
Unleashing insights
In the competitive landscape of biotechnology, cost efficiency is paramount. Agios Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc. have shown contrasting trends in their cost of revenue from 2014 to 2023. Agios experienced a significant decline of approximately 90% in its cost of revenue, from a peak in 2017 to a low in 2018. This suggests a strategic shift or operational efficiency improvements. Meanwhile, Iovance's cost of revenue remained relatively stable, with a slight increase of around 14% over the same period, indicating consistent operational costs.
The data reveals that Agios's cost-cutting measures were more pronounced, especially post-2017, while Iovance maintained a steady course. This analysis provides valuable insights into how these companies manage their resources, offering a glimpse into their strategic priorities in the ever-evolving biotech sector.
Cost Insights: Breaking Down Johnson & Johnson and Iovance Biotherapeutics, Inc.'s Expenses
Cost of Revenue Trends: Pfizer Inc. vs Iovance Biotherapeutics, Inc.
Comparing Cost of Revenue Efficiency: Amgen Inc. vs Iovance Biotherapeutics, Inc.
Cost of Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Agios Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Neurocrine Biosciences, Inc. vs Agios Pharmaceuticals, Inc.
Jazz Pharmaceuticals plc vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Amneal Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
MorphoSys AG vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Agios Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Agios Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Cost of Revenue Trends: Iovance Biotherapeutics, Inc. vs Viridian Therapeutics, Inc.